SOURCE: ChromaGen Vision

December 02, 2011 16:22 ET

ChromaGen Launches "We Read Better" Blog

New Social Media Platform Creates a Place Where People Interested in the Art of Reading and Concerned About Reading Disorders Can Connect

PHILADELPHIA, PA--(Marketwire - Dec 2, 2011) - ChromaGen Vision today announced the launch of its "We Read Better" blog, an interactive platform that will educate and connect ChromaGen wearers, eye care professionals and those with a general interest in reading.

We Read Better will focus on all topics that relate to reading better. It will share the latest information about reading, provide references for people who have reading difficulties and highlight the latest technologies and developments that are helping people combat the symptoms of reading disorders.

"Social media channels have revolutionized the way people get information and connect to one another," said Ted Edwards, CEO of ChromaGen. "ChromaGen has established relationships on Twitter, Facebook, and LinkedIn with networks of people interested in reading and reading disorders. The new We Read Better blog will further these important connections, provide helpful resources and information, and encourage enlightening conversation about reading disorders, challenges associated with them and viable treatment options."

The open forum of We Read Better enables a conversation among visitors. It is designed to educate, inform and put a smile on the face of anyone looking to explore the art of reading. We Read Better will showcase some of the best and brightest minds who are working to improve reading, feature stories from real families struggling with reading disorders and share the latest articles from all over the world.

To learn more about We Read Better, engage in the conversation and share your story, visit us at

We Read Better was created by Bad Rhino, a Social Media Marketing Firm in Philadelphia. Visit Bad Rhino on the web at

To learn more about ChromaGen, visit or call 855-473-2323.

About ChromaGen

ChromaGen™ is a life changing aid for visual reading disorders often associated with dyslexia and an optical corrective solution for color deficiency (more commonly known as color blindness). ChromaGen provides dramatic results immediately with no side effects or invasive procedures. The lenses can be incorporated into any existing prescription. ChromaGen has been cleared by the U.S. Food and Drug Administration (FDA) and has patent protection that runs through 2028. For more information about ChromaGen, please visit

Contact Information

  • ChromaGen
    148 W. State Street
    Suite 305
    Kennett Square, PA 19348